clinical trials bpc-157 Integrative Peptides BPC-157: complete guide to oral peptide supplements foxo4-dri clinical trial nct BPC-157
Description
Pharmaceutical-grade quality
Unlike other growth factors, which need carrier(s) addition, and are rapidly destroyed in human gastric juice, BPC 157 is native and stable in human gastric juice for more than 24 h (Sikiric et al., 2018
However, few large-scale clinical trials have been performed to confirm the role of these metabolites in the treatment of IBD
It pairs 1% GHK-Cu with Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7
